fullerene c60 has been researched along with 2,6-nonadienal, (e,z)-isomer in 1 studies
| Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) | Studies (2,6-nonadienal, (e,z)-isomer) | Trials (2,6-nonadienal, (e,z)-isomer) | Recent Studies (post-2010) (2,6-nonadienal, (e,z)-isomer) |
|---|---|---|---|---|---|
| 3,806 | 5 | 2,170 | 11 | 0 | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoshima, H; Kato, S; Miwa, N; Saitoh, Y | 1 |
1 other study(ies) available for fullerene c60 and 2,6-nonadienal, (e,z)-isomer
| Article | Year |
|---|---|
Defensive effects of fullerene-C60 dissolved in squalane against the 2,4-nonadienal-induced cell injury in human skin keratinocytes HaCaT and wrinkle formation in 3D-human skin tissue model.
Topics: Aldehydes; Cell Line; Cell Survival; Drug Interactions; Fullerenes; Humans; In Situ Nick-End Labeling; Keratinocytes; Models, Biological; Skin Aging; Squalene | 2010 |